By integrating cis-expression quantitative trait loci analyses in Braineac and GTEx, we further identified GGNBP2, ATXN3, and SLC9A8 as novel ALS risk genes. The gene discussed is ATXN3; the disease is amyotrophic lateral sclerosis.